Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

Trials ◽

10.1186/s13063-016-1419-9 ◽

2016 ◽

Vol 17 (1) ◽

Author(s):

Liang Dai ◽

Linda L. D. Zhong ◽

Yan Cao ◽

Wei Chen ◽

Ying Cheng ◽

...

Keyword(s):

Study Protocol ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial

Trials ◽

10.1186/s13063-020-04447-3 ◽

2020 ◽

Vol 21 (1) ◽

Author(s):

Jonathan Rilinger ◽

Winfried V. Kern ◽

Daniel Duerschmied ◽

Alexander Supady ◽

Christoph Bode ◽

...

Keyword(s):

Randomised Controlled Trial ◽

Study Protocol ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Randomised Controlled

Download Full-text

Evaluation of the efficacy and safety of a Chinese herbal formula (RCM-106) for atopic dermatitis: study protocol for a randomised, double-blind, placebo-controlled trial in children

BMJ Open ◽

10.1136/bmjopen-2013-003906 ◽

2013 ◽

Vol 3 (12) ◽

pp. e003906 ◽

Author(s):

Hsiewe Ying Tan ◽

Anthony L Zhang ◽

Charlie C Xue ◽

Dacan Chen ◽

Cliff Da Costa ◽

...

Keyword(s):

Atopic Dermatitis ◽

Study Protocol ◽

Controlled Trial ◽

Herbal Formula ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Chinese Herbal Formula ◽

Download Full-text

Efficacy and safety of Shen-Yuan-Dan capsules for peri-procedural myocardial injury following percutaneous coronary intervention: study protocol for a randomized, double-blind, placebo-controlled trial

Annals of Translational Medicine ◽

10.21037/atm.2018.09.44 ◽

2019 ◽

Vol 7 (6) ◽

pp. 119-119

Author(s):

Xiang Li ◽

Xiao-Lei Lai ◽

Yu-Tong Fei ◽

Ju-Ju Shang ◽

Qi Zhou ◽

...

Keyword(s):

Percutaneous Coronary Intervention ◽

Study Protocol ◽

Myocardial Injury ◽

Intervention Study ◽

Controlled Trial ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Percutaneous Coronary

Download Full-text

EHMTI-0202. Study protocol of BoTN: a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of botulinum toxin injections in the treatment of trigeminal neuralgia

The Journal of Headache and Pain ◽

10.1186/1129-2377-15-s1-c9 ◽

2014 ◽

Vol 15 (S1) ◽

Author(s):

J Burmeister ◽

D Holle ◽

E Bock ◽

C Ose ◽

HC Diener ◽

...

Keyword(s):

Botulinum Toxin ◽

Trigeminal Neuralgia ◽

Study Protocol ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Botulinum Toxin Injections

Download Full-text

Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial

Trials ◽

10.1186/s13063-018-3105-6 ◽

2018 ◽

Vol 19 (1) ◽

Author(s):

Tomohiro Koga ◽

Shuntaro Sato ◽

Junya Miyamoto ◽

Naoko Hagimori ◽

Yurika Kawazoe ◽

...

Keyword(s):

Familial Mediterranean Fever ◽

Study Protocol ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Mediterranean Fever

Download Full-text

Efficacy and safety of Sijunzi Decoction for chronic fatigue syndrome with spleen deficiency pattern: study protocol for a randomized, double-blind, placebo-controlled trial

Annals of Translational Medicine ◽

10.21037/atm.2019.09.136 ◽

2019 ◽

Vol 7 (20) ◽

pp. 587-587 ◽

Author(s):

Liang Dai ◽

Wen-Jun Zhou ◽

Miao Wang ◽

Shi-Gao Zhou ◽

Guang Ji

Keyword(s):

Chronic Fatigue Syndrome ◽

Study Protocol ◽

Controlled Trial ◽

Chronic Fatigue ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Spleen Deficiency ◽

Fatigue Syndrome

Download Full-text

The efficacy and safety of a proposed herbal moisturising cream for dry skin and itch relief: a randomised, double-blind, placebo-controlled trial- study protocol

BMC Complementary and Alternative Medicine ◽

10.1186/1472-6882-13-330 ◽

2013 ◽

Vol 13 (1) ◽

Author(s):

Dong-Hyo Lee ◽

Eun-Sung Seo ◽

Jin-Tae Hong ◽

Gang-Tai Lee ◽

Young-Kyoung You ◽

...

Keyword(s):

Study Protocol ◽

Controlled Trial ◽

Efficacy And Safety ◽

Dry Skin ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088945.542078 ◽

2007 ◽

Author(s):

Jonathan Schapiro

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108987.566149 ◽

2008 ◽

Author(s):

Johann Gudjonsson

Keyword(s):

Monoclonal Antibody ◽

Controlled Trial ◽

Interleukin 12 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958672.793516776 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Irritable Bowel Syndrome ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text